Dr. Reddy's Laboratories Ltd (RDY) Social Stream
DR REDDYS LABORATORIES LTD (RDY) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering DR REDDYS LABORATORIES LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 2 | $80 | $75.7 | $77.85 | $69.38 | 12.21% |
| 2022-01-06 | 2 | $80 | $75.5 | $77.75 | $69.38 | 12.06% |
| 2022-01-28 | 1 | $80 | $68.5 | $74.25 | $69.38 | 7.02% |
| 2022-03-30 | 1 | $80 | $66.4 | $73.2 | $69.38 | 5.51% |
| 2022-04-28 | 1 | $69 | $66.4 | $67.7 | $69.38 | -2.42% |
| 2022-05-19 | 3 | $69 | $59 | $64.466 | $69.38 | -7.08% |
| 2022-06-21 | 3 | $70 | $59 | $64.8 | $69.38 | -6.6% |
| 2022-07-25 | 3 | $68 | $59 | $65 | $69.38 | -6.31% |
| 2022-08-13 | 3 | $68 | $57 | $63.666 | $69.38 | -8.24% |
| 2022-09-17 | 3 | $69 | $57 | $64 | $69.38 | -7.75% |
| 2022-10-13 | 3 | $69 | $57 | $63.033 | $69.38 | -9.15% |
| 2022-10-25 | 3 | $66.001 | $57 | $62.033 | $69.38 | -10.59% |
| 2022-10-30 | 3 | $66.001 | $57 | $61.5 | $69.38 | -11.36% |
| 2023-01-05 | 3 | $67 | $57 | $62.266 | $69.38 | -10.25% |
| 2023-01-27 | 3 | $67 | $57 | $61.5 | $69.38 | -11.36% |
| 2023-02-27 | 4 | $67 | $57 | $61.533 | $69.38 | -11.31% |
| 2023-03-16 | 4 | $67 | $60.6 | $62.866 | $69.38 | -9.39% |
| 2023-04-18 | 4 | $67 | $61 | $65 | $69.38 | -6.31% |
| 2023-05-10 | 4 | $68 | $64 | $66.333 | $69.38 | -4.39% |
| 2023-06-01 | 4 | $70 | $64 | $67.333 | $69.38 | -2.95% |
| 2023-06-20 | 4 | $70 | $67 | $68.333 | $69.38 | -1.51% |
| 2023-10-28 | 4 | $77.5 | $70 | $73.5 | $69.38 | 5.94% |
| 2023-10-31 | 4 | $77.5 | $73 | $75.166 | $69.38 | 8.34% |
The Trend in the Analyst Price Target
Over the past 40 weeks, RDY's average price target has gone up $13.67.
Over the past 42 weeks, RDY's average upside potential has been 14.22%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 4 | 67.0 | 57 | 61.500 | 53.34 | 15.3% |
| 2023-02-27 | 4 | 67.0 | 57 | 61.533 | 53.74 | 14.5% |
| 2023-06-20 | 4 | 70.0 | 67 | 68.333 | 60.41 | 13.12% |
| 2023-10-27 | 4 | 77.5 | 70 | 73.500 | 65.05 | 12.99% |
| 2023-10-31 | 4 | 77.5 | 73 | 75.166 | 65.13 | 15.41% |
RDY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 0 | 0 | 1 | 1 | 4 |
The Trend in the Broker Recommendations
RDY's average broker recommendation rating worsened by 0.33 over the prior 17 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, DR REDDYS LABORATORIES LTD's number of analysts covering the stock is greater than 208.19% of them.
- In terms of how DR REDDYS LABORATORIES LTD fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -24.56% of that group.
- In terms of how DR REDDYS LABORATORIES LTD fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 361.69% of that group.
- RDY has a higher average analyst price target than 2100.2% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, BGNE, GRFS, and CTLT are the three stocks most similar to DR REDDYS LABORATORIES LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is RDY a Buy, Hold or Sell? See the POWR Ratings now!